Mesalamine | C7H7NO3 - PubChem
Mechanism of vedolizumab. This image is modified from their original... | Download Scientific Diagram
Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence - DESREUMAUX - 2006 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
5-ASA | IBD Clinic
Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease - Allgayer - 2003 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases | Pharmacology
DRUG TREATMENT OF INFLAMMATORY BOWEL DISEASE. Objectives Describe the mechanism of action, pharmacokinetics and adverse effects of drugs in IBD. - ppt download
A review of the biological and pharmacological activities of mesalazine or 5-aminosalicylic acid (5-ASA): an anti-ulcer and anti-oxidant drug | SpringerLink
Prof. Hanan Hagar Pharmacology Unit College of Medicine - ppt download
Classical and recent advances in the treatment of inflammatory bowel diseases - Brazilian Journal of Medical and Biological Research
Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evid | DDDT
Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells | American Journal of Physiology-Gastrointestinal and Liver Physiology
Mechanism of Action of Aminosalicylates
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
An Overview of Novel and Emerging Therapies for Inflammatory Bowel Disease - European Medical Journal
Pharmacogenomics in the treatment of inflammatory bowel disease | Pharmacogenomics
Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence - DESREUMAUX - 2006 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal? - Abstract - Europe PMC
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
Drugs used in IBD and biological and immune therapy of IBD ” - ppt download
Aminosalicylates
Inflammatory Bowel Disease | NEJM
Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease
